Ipsen S.A.

ENXTPA:IPN Stock Report

Market Cap: €10.0b

Ipsen Future Growth

Future criteria checks 1/6

Ipsen is forecast to grow earnings and revenue by 9.4% and 3.5% per annum respectively. EPS is expected to grow by 8.5% per annum. Return on equity is forecast to be 14% in 3 years.

Key information

9.4%

Earnings growth rate

8.45%

EPS growth rate

Pharmaceuticals earnings growth12.1%
Revenue growth rate3.5%
Future return on equity14.00%
Analyst coverage

Good

Last updated27 Oct 2025

Recent future growth updates

Recent updates

Ipsen (EPA:IPN) Seems To Use Debt Rather Sparingly

Oct 28
Ipsen (EPA:IPN) Seems To Use Debt Rather Sparingly

Are Investors Undervaluing Ipsen S.A. (EPA:IPN) By 41%?

Sep 07
Are Investors Undervaluing Ipsen S.A. (EPA:IPN) By 41%?

Investors Interested In Ipsen S.A.'s (EPA:IPN) Earnings

Jul 13
Investors Interested In Ipsen S.A.'s (EPA:IPN) Earnings

Ipsen (EPA:IPN) Is Increasing Its Dividend To €1.40

May 16
Ipsen (EPA:IPN) Is Increasing Its Dividend To €1.40

Ipsen's (EPA:IPN) Upcoming Dividend Will Be Larger Than Last Year's

Apr 29
Ipsen's (EPA:IPN) Upcoming Dividend Will Be Larger Than Last Year's

Ipsen's (EPA:IPN) Dividend Will Be Increased To €1.40

Apr 14
Ipsen's (EPA:IPN) Dividend Will Be Increased To €1.40
User avatar

Cabometyx And Tovorafenib Approvals May Strengthen Oncology Portfolio In 2025

Expansion of Onivyde and new product approvals could significantly increase revenue and strengthen market positions in key medical segments.

Ipsen's (EPA:IPN) Soft Earnings Don't Show The Whole Picture

Feb 21
Ipsen's (EPA:IPN) Soft Earnings Don't Show The Whole Picture

Is Ipsen S.A. (EPA:IPN) Trading At A 44% Discount?

Feb 14
Is Ipsen S.A. (EPA:IPN) Trading At A 44% Discount?

Pinning Down Ipsen S.A.'s (EPA:IPN) P/E Is Difficult Right Now

Jan 20
Pinning Down Ipsen S.A.'s (EPA:IPN) P/E Is Difficult Right Now

Is Ipsen (EPA:IPN) Using Too Much Debt?

Dec 24
Is Ipsen (EPA:IPN) Using Too Much Debt?

Earnings and Revenue Growth Forecasts

ENXTPA:IPN - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20274,1307727681,08611
12/31/20263,9057137371,09012
12/31/20253,77271767094211
6/30/20253,760448595976N/A
3/31/20253,667402364946N/A
12/31/20243,575356133916N/A
6/30/20243,435664212903N/A
3/31/20243,371641444884N/A
12/31/20233,306617677866N/A
6/30/20233,282406764972N/A
3/31/20233,219500741971N/A
12/31/20223,156593719971N/A
9/30/20223,053656615972N/A
6/30/20222,950719512973N/A
3/31/20222,849675494933N/A
12/31/20212,749631475893N/A
9/30/20212,712626570860N/A
6/30/20212,676622665827N/A
3/31/20212,681585649799N/A
12/31/20202,686548632771N/A
9/30/20202,697249564750N/A
6/30/20202,707-50496729N/A
3/31/20202,700-53421678N/A
12/31/20192,693-55347628N/A
9/30/20192,605176310591N/A
6/30/20192,516406272555N/A
3/31/20192,432397N/A563N/A
12/31/20182,348388N/A571N/A
9/30/20182,258365N/AN/AN/A
6/30/20182,167343N/A502N/A
3/31/20182,090307N/A463N/A
12/31/20172,012270N/A423N/A
9/30/20171,923243N/AN/AN/A
6/30/20171,834217N/A316N/A
3/31/20171,753221N/A317N/A
12/31/20161,671226N/A318N/A
9/30/20161,623229N/AN/AN/A
6/30/20161,575233N/A318N/A
3/31/20161,548211N/A271N/A
12/31/20151,520189N/A224N/A
9/30/20151,468165N/A225N/A
6/30/20151,416140N/A227N/A
3/31/20151,374147N/A237N/A
12/31/20141,332154N/A246N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: IPN's forecast earnings growth (9.4% per year) is above the savings rate (1.9%).

Earnings vs Market: IPN's earnings (9.4% per year) are forecast to grow slower than the French market (12.4% per year).

High Growth Earnings: IPN's earnings are forecast to grow, but not significantly.

Revenue vs Market: IPN's revenue (3.5% per year) is forecast to grow slower than the French market (5.6% per year).

High Growth Revenue: IPN's revenue (3.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: IPN's Return on Equity is forecast to be low in 3 years time (14%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/31 12:15
End of Day Share Price 2025/10/31 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ipsen S.A. is covered by 28 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Richard SilverBarclays
Charles PitmanBarclays
Charles PitmanBarclays